04/03/2025
10:00 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
5:10 AM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
03/21/2025
4:20 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 424B4 | |
01/27/2025
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
01/15/2025
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
01/08/2025
3:11 PM | Panis Jaydriane (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
3:47 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/30/2024
3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VRPX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/18/2024
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:15 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
4:29 PM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
11/29/2024
5:39 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
4:01 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
5:06 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:20 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
11/07/2024
4:01 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/28/2024
3:08 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/18/2024
4:28 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/10/2024
4:07 PM | Virpax Pharmaceuticals (Filer)
| Form 10-K/A | |
10/10/2024
4:08 PM | Virpax Pharmaceuticals (Filer)
| Form 10-K/A | |
10/09/2024
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K/A | |
10/04/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:12 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
8:05 AM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
08/13/2024
6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:26 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/26/2024
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
6:45 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
5:40 PM | Su Judy (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/15/2024
7:00 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:09 PM | Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
3:10 PM | Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
11:48 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:00 PM | Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
July 2025 Rule Change to Impact Retirement Investors (Ad) There's a massive change from a new rule going into effect this July.
And it's one the Big Banks are already using to their advantage…
It allows them to treat this new asset like actual cash. Yes, Send Me My FREE Retirement Guide |
07/09/2024
3:01 PM | Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2024
3:02 PM | Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:03 PM | Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | Virpax Pharmaceuticals (Filer)
| Form DEFA14A | |
07/08/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
4:09 PM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
06/12/2024
4:11 PM | Virpax Pharmaceuticals (Filer)
| Form ARS | |
